Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Denali Therapeutics (DNLI) Tax Rate (2019 - 2023)

Denali Therapeutics has reported Tax Rate over the past 5 years, most recently at 0.03% for Q4 2023.

  • Quarterly Tax Rate fell 3.0% to 0.03% in Q4 2023 from the year-ago period, while the trailing twelve-month figure was 0.02% through Dec 2023, down 19.0% year-over-year, with the annual reading at 0.02% for FY2025, 0.0% changed from the prior year.
  • Tax Rate was 0.03% for Q4 2023 at Denali Therapeutics, down from 0.01% in the prior quarter.
  • Over five years, Tax Rate peaked at 0.76% in Q4 2021 and troughed at 0.13% in Q2 2020.
  • The 5-year median for Tax Rate is 0.09% (2020), against an average of 0.17%.
  • Year-over-year, Tax Rate skyrocketed 42bps in 2021 and then crashed -75bps in 2022.
  • A 5-year view of Tax Rate shows it stood at 0.24% in 2019, then skyrocketed by 37bps to 0.33% in 2020, then skyrocketed by 126bps to 0.76% in 2021, then crashed by -99bps to 0.01% in 2022, then crashed by -513bps to 0.03% in 2023.
  • Per Business Quant, the three most recent readings for DNLI's Tax Rate are 0.03% (Q4 2023), 0.01% (Q4 2022), and 0.05% (Q2 2022).